Dr. Volker Diehl from the University of Cologne Discusses Brentuximab Vedotin
Volker Diehl, MD
Advertisement
Articles by Volker Diehl, MD
Dr. Volker Diehl from the University of Cologne, Germany, Compares US and EU Hodgkin Lymphoma Staging
Dr. Volker Diehl from the University of Cologne, Germany on the Unique Nature of Hodgkin's Lymphoma
Advertisement
Latest Updated Articles
Dr. Diehl on the Unique Nature of Hodgkin's LymphomaPublished: November 8th 2011 | Updated:
Dr. Diehl Compares US and EU Hodgkin Lymphoma StagingPublished: November 14th 2011 | Updated:
Dr. Diehl Discusses Brentuximab VedotinPublished: November 21st 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
5